申请人:Von Matt Peter
公开号:US20060058356A1
公开(公告)日:2006-03-16
Provided are compounds of formula I
which are useful in the treatment or prevention of disorders or diseases mediated by T lymphocytes and/or PKC or GSK-3 BETA.
提供了一些I式化合物,这些化合物在治疗或预防由T淋巴细胞和/或PKC或GSK-3 BETA介导的疾病或疾病方面是有用的。